This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Jale Muslehiddinoglu, PhD
Vice President of Strategic Innovation at ST Pharm
Speaker

Profile

Jale Muslehiddinoglu, Ph.D. is Vice President of Strategic Innovation at ST Pharm. Jale has 22 years of industry experience working at pharma and biotech companies and leading technical teams to develop, implement and commercialize API processes. Prior to joining ST Pharm, Jale developed strategies and capabilities for new modalities. She played a key role building lab and production capabilities for oligonucleotides from development, manufacturing and supply chain perspectives. Jale introduced novel approaches for the development of oligonucleotides. She involved in initiatives like EPOC, oligonucleotide networking event.
Jale received her doctorate in chemical engineering from Pennsylvania State University.

Agenda Sessions

  • Beyond Capacity: Rethinking Oligonucleotide Development and Manufacturing for Next-Generation Modalities

    12:20pm